Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | GPR3 | P46089 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.44 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30819315 | 1.00 | ALDH1A1 (0.55) | ALDH1A1ALOX15MAOBMAOAGPR3 | |
| SCHEMBL10619559 | 0.75 | ALDH1A1 (0.55) | ALDH1A1ALOX15MAOBGPR3POLB | |
| SCHEMBL2473539 | 0.75 | BCKDK (0.46) | ALDH1A1POLBMAPTLMNACA9 | |
| SCHEMBL2472396 | 0.74 | MAOA (0.46) | ALDH1A1ALOX15MAOBMAOAPOLB | |
| SCHEMBL5713277 | 0.72 | ALDH1A1 (0.47) | ALDH1A1ALOX15GPR3POLBMAPT | |
| SCHEMBL2471786 | 0.72 | CYP1A1 (0.50) | POLBMAPTTRPM4KDM4ENPSR1 | |
| SCHEMBL466086 | 0.71 | ALDH1A1 (1.00) | ALDH1A1ALOX15MAOBMAOAGPR3 | |
| SCHEMBL31676779 | 0.71 | KDM4E (0.59) | ALDH1A1ALOX15MAOBMAOAGPR3 | |
| SCHEMBL21624260 | 0.71 | KDM4E (0.59) | ALDH1A1ALOX15MAOBMAOAGPR3 | |
| SCHEMBL2475121 | 0.69 | ALDH1A1 (0.38) | ALDH1A1MAOBMAOAPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0161163-B1 | 4-HYDROXY-2H-1-BENZOTHIOPYRAN-2-ONE DERIVATIVES, THEIR PREPARATION AND USES | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1987-09-23 | — | — | EP | claimed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4580594-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) | 2025-07-09 | — | — | EP | disclosed |
| US-20240142665-A1 | OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2024-05-02 | — | — | US | disclosed |
| WO-2024046834-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | ANALYTICON DISCOVERY GMBH (DE) | 2024-03-07 | — | — | WO | disclosed |
| EP-4331564-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | Analyticon Discovery GmbH (DE) | 2024-03-06 | — | — | EP | disclosed |
| EP-4263513-A1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2023-10-25 | — | — | EP | disclosed |
| US-20230165242-A1 | RODENTICIDAL BAIT AND METHOD OF CONTROLLING TARGET HARMFUL RODENTS | LIPHATECH INC (FR) | 2023-06-01 | — | — | US | disclosed |
| CN-113150006-B | Pyran compound and synthetic method thereof | 五邑大学 | 2022-07-05 | — | — | CN | disclosed |
| EP-0644198-A1 | Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors | STERLING WINTHROP INC. (US) | 1995-03-22 | — | — | EP | disclosed |
| US-5382572-A | Viricides | SCHERING CORPORATION (US) | 1995-01-17 | — | — | US | disclosed |
| EP-0547145-A1 | ANTIVIRAL 2(1H)-QUINOLINONE COMPOUNDS | SCHERING CORPORATION (US) | 1993-06-23 | — | — | EP | disclosed |
| EP-0539372-A1 | THERAPEUTIC AGENTS | The Boots Company PLC (GB) | 1993-05-05 | — | — | EP | disclosed |
| WO-1992004326-A1 | ANTIVIRAL COMPOUNDS | SCHERING CORPORATION (US) | 1992-03-19 | — | — | WO | disclosed |
| WO-1991011448-A1 | THERAPEUTIC AGENTS | THE BOOTS COMPANY PLC (GB) | 1991-08-08 | — | — | WO | disclosed |
| US-4957931-A | ANTICONVULSANTS, TREATMENT OF EPILEPSY | CIBA-GEIGY CORPORATION (US) | 1990-09-18 | — | — | US | disclosed |
| US-4859691-A | Certain 1,2-benzisoxazole derivatives | CIBA-GEIGY CORPORATION (US) | 1989-08-22 | — | — | US | disclosed |
| US-4585786-A | Rodenticidal 4-hydroxy-2H-1-benzothiopyran-2-one derivatives, compositions, and method of use therefor | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1986-04-29 | — | — | US | disclosed |
| EP-0161163-A1 | 4-Hydroxy-2H-1-benzothiopyran-2-one derivatives, their preparation and uses | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1985-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165242-A1 | RODENTICIDAL BAIT AND METHOD OF CONTROLLING TARGET HARMFUL RODENTS | VDR, CYP2R1, CYP24A1 | ALDH1A1 3777/4885ALOX15 1560/4885MAOB 4826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.